Treating the Metabolic Syndrome by Fecal Transplantation—Current Status
The intestinal microbiome (IM) is important for normal gastrointestinal (GI) and other organ systems’ functioning. An alteration in the normal IM, dysbiosis, and changes in intestinal motility result in microorganisms’ overgrowth and an alteration in intestinal permeability. The gut–brain axis is al...
Main Authors: | Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/10/5/447 |
Similar Items
-
The Intestinal Microbiome and the Metabolic Syndrome—How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD)
by: Stephen D. H. Malnick, et al.
Published: (2023-08-01) -
Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01) -
Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations
by: Anton Gillessen, MD, et al.
Published: (2022-01-01) -
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
by: Eileen L. Yoon, et al.
Published: (2024-01-01) -
Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality
by: Yuri Ogasawara, et al.
Published: (2023-06-01)